Published in J Reprod Med on May 01, 1988
Decreased rate of obstetrical anal sphincter laceration is associated with change in obstetric practice. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.89
Prevalence and outcome of teenage hospital births at the buea health district, South West Region, Cameroon. Reprod Health (2015) 0.81
Assessing the association of oxytocin augmentation with obstetric anal sphincter injury in nulliparous women: a population-based, case-control study. BMJ Open (2014) 0.79
Adolescent deliveries in rural Cameroon: an 8-year trend, prevalence and adverse maternofoetal outcomes. Reprod Health (2017) 0.75
Behavioral changes in developing mice after prenatal exposure to paroxetine (Paxil) Am J Obstet Gynecol (1999) 1.63
Projections of population-based twinning rates through the year 2100. J Reprod Med (1999) 1.42
Novel Gal3 proteins showing altered Gal80p binding cause constitutive transcription of Gal4p-activated genes in Saccharomyces cerevisiae. Mol Cell Biol (1997) 1.37
The Gal3p-Gal80p-Gal4p transcription switch of yeast: Gal3p destabilizes the Gal80p-Gal4p complex in response to galactose and ATP. Mol Cell Biol (1999) 1.30
Umbilical cord length and intrapartum complications. Obstet Gynecol (1981) 1.00
Multiple nuchal cord entanglements and intrapartum complications. Am J Obstet Gynecol (1995) 0.98
Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Obstet Gynecol (1997) 0.97
Influence of spontaneous or induced labor on delivering the macrosomic fetus. Am J Perinatol (1995) 0.94
Perinatal outcome after a prolonged second stage of labor. J Reprod Med (1990) 0.93
Effectiveness of prostaglandin E2 intracervical gel (Prepidil), with immediate oxytocin, versus vaginal insert (Cervidil) for induction of labor. Am J Obstet Gynecol (1998) 0.93
Antepartum prediction of the postmature infant. Obstet Gynecol (1982) 0.92
Fetal movement counts. Obstet Gynecol Clin North Am (1999) 0.90
Intravaginal prostaglandin E2 for cervical ripening and initiation of labor. Comparison of a multidose gel and single, controlled-release pessary. J Reprod Med (1994) 0.90
Nuchal cord encirclements and risk of stillbirth. Int J Gynaecol Obstet (2000) 0.90
Nuchal cord entanglements and gestational age. Am J Perinatol (1997) 0.89
Pregnancy and delivery following bilateral ureteral transplantation to the bowel for exstrophy of the bladder. Pac Med Surg (1967) 0.88
Clinical significance of perceptible fetal motion. Am J Obstet Gynecol (1980) 0.87
Burns and pregnancy. Clin Perinatol (1983) 0.87
Double-blind comparison of intravenous butorphanol (Stadol) and fentanyl (Sublimaze) for analgesia during labor. Am J Obstet Gynecol (1994) 0.87
Diagnosis and classification of diabetes mellitus: highlights from the American Diabetes Association. J Reprod Med (1997) 0.86
Prenatal use of medications by women giving birth at a university hospital. South Med J (1997) 0.86
Microlaparoscopic technique for partial salpingectomy using bipolar electrocoagulation. J Reprod Med (2001) 0.85
Prior third- or fourth-degree perineal tears and recurrence risks. Int J Gynaecol Obstet (1999) 0.84
Patients' acceptance of monitoring fetal movement. A randomized comparison of charting techniques. J Reprod Med (1992) 0.84
Multiple gestation: time interval between delivery of the first and second twins. Obstet Gynecol (1984) 0.84
Effects of intracervical prostaglandin E2 on fetal heart rate and uterine activity patterns in the presence of oligohydramnios. Am J Obstet Gynecol (1995) 0.83
Low backache during pregnancy. Acute hemodynamic effects of a lumbar support. J Reprod Med (1999) 0.83
Uterine hyperstimulation after low-dose prostaglandin E2 therapy: tocolytic treatment in 181 cases. Am J Obstet Gynecol (1990) 0.83
Indications for labor induction. Differences between university and community hospitals. J Reprod Med (2000) 0.83
Blastocyst transfer in human in vitro fertilization. A solution to the multiple pregnancy epidemic. J Reprod Med (2000) 0.82
A placebo-controlled, blinded comparison between betamethasone and dexamethasone to enhance lung maturation in the fetal mouse. J Soc Gynecol Investig (1997) 0.82
Cross-over trial comparing maternal acceptance of two fetal movement charts. J Matern Fetal Neonatal Med (2003) 0.82
Double-blind comparison of intravaginal prostaglandin E2 gel and "chip" for preinduction cervical ripening. Am J Obstet Gynecol (1990) 0.81
Parenteral nutrition in obstetric patients. Nutr Clin Pract (1990) 0.81
Coital activity and premature delivery. Am J Obstet Gynecol (1980) 0.81
Clinical implications from monitoring fetal activity. Am J Obstet Gynecol (1982) 0.81
Relation of mild idiopathic polyhydramnios to perinatal outcome. Obstet Gynecol (1992) 0.81
Maternal perception of fetal movement and perinatal outcome. Obstet Gynecol (1980) 0.80
Early postpartum discharge at a university hospital. Outcome analysis. J Reprod Med (2001) 0.80
A cost-minimization analysis of intracervical prostaglandin E2 for cervical ripening in an outpatient versus inpatient setting. Clin Ther (1997) 0.80
Fetal habituation to vibroacoustic stimulation in uncomplicated term pregnancies. Am J Perinatol (1991) 0.79
Placebo-controlled comparison between a single dose and a multidose of betamethasone in accelerating lung maturation of mice offspring. Am J Obstet Gynecol (1998) 0.79
Mandated preterm delivery: its prevalence and impact at a tertiary referral center. J Matern Fetal Med (2001) 0.78
Chronic prenatal exposure to paroxetine (Paxil) and cognitive development of mice offspring. Neurotoxicol Teratol (2000) 0.78
Second-trimester pregnancy termination for genetic abnormalities. J Reprod Med (1982) 0.78
Uterine rupture after use of a prostaglandin E2 vaginal insert during vaginal birth after cesarean. A report of two cases. J Reprod Med (1999) 0.78
Prophylactic antibiotics during cesarean section: an overview of prior clinical investigations. Clin Perinatol (1983) 0.78
Krukenberg tumor--report of two cases. Nebr Med J (1972) 0.78
Patterns of uterine activity after intravaginal prostaglandin E2 during preinduction cervical ripening. Am J Obstet Gynecol (1991) 0.78
Gestational diabetes screening in a private, midwestern American population. Am J Obstet Gynecol (1987) 0.78
Mid-gestational abortion for medical or genetic indications. Clin Obstet Gynaecol (1986) 0.78
Impact of multiple antenatal doses of betamethasone on growth and development of mice offspring. Am J Obstet Gynecol (1997) 0.78
Combined continuous and demand narcotic dosing for patient-controlled analgesia after cesarean section. Anesthesiol Rev (1992) 0.78
Outpatient cervical ripening using a sustained-release prostaglandin E2 vaginal insert. J Reprod Med (2001) 0.78
Partial attenuation of hemodynamic responses to rapid sequence induction and intubation with labetalol. J Clin Anesth (1989) 0.78
Double-blind comparison of intracervical and intravaginal prostaglandin E2 for cervical ripening and induction of labor. Am J Obstet Gynecol (1994) 0.77
Intraventricular hemorrhage in preterm twin gestation infants. J Perinatol (1988) 0.77
Influence of intravenous fentanyl on fetal biophysical parameters during labor. J Matern Fetal Med (1996) 0.77
Obstetric care and intraventricular hemorrhage in the low birth weight infant. Obstet Gynecol (1983) 0.77
Management of envenomations during pregnancy. Clin Toxicol (Phila) (2013) 0.77
First-trimester hyperglycosylated human chorionic gonadotropin and development of hypertension. Prenat Diagn (2013) 0.77
Patient-controlled analgesia in obstetrics and gynecology. Obstet Gynecol (1991) 0.77
Long-term plasmapheresis in the homozygous hyperlipidemic patient. Am Heart J (1991) 0.77
Mitral valve prolapse and pregnancy. Am J Obstet Gynecol (1981) 0.77
Effect of serum lipids on radioimmunoassays of unconjugated estriol in serum. Clin Chem (1981) 0.76
Patterns of uterine activity. Using oxytocin after intracervical PGE2. J Reprod Med (1997) 0.76
Managing pregnancy-related nocturnal nasal congestion. The external nasal dilator. J Reprod Med (1996) 0.76
Self-monitoring of blood pressure during pregnancy. Am J Obstet Gynecol (1984) 0.76
Transvaginal sonography of cervical width and length during pregnancy. J Ultrasound Med (1992) 0.76
Blood pressure self-monitoring during pregnancy: practical considerations. Am J Obstet Gynecol (1991) 0.76
Intravenous magnesium sulfate for premature labor: comparison between twin and singleton gestations. Am J Perinatol (1995) 0.75
Chronic prenatal exposure to phenobarbital and long-term behavior effects on mice offspring. J Matern Fetal Neonatal Med (2004) 0.75
Counseling by telephone: a toll-free service to improve prenatal care. J Reprod Med (1982) 0.75
Drug prescribing for chronic medical disorders during pregnancy: an overview. Am J Obstet Gynecol (1986) 0.75
A volunteer librarian's progress. Nebr Med J (1979) 0.75
Drugs during pregnancy: are any really safe? Nebr Med J (1986) 0.75
Protection of maternal iron stores in pregnancy. Panel discussion. J Reprod Med (1987) 0.75
Mitral valve prolapse. Echocardiographic changes during pregnancy. J Reprod Med (1987) 0.75
Furosemide (Lasix) challenge test in assessing bilateral fetal hydronephrosis. Am J Obstet Gynecol (1983) 0.75
A study of fetal acceleration tests. Am J Obstet Gynecol (1978) 0.75
Management of the uncomplicated postdate pregnancy. J Reprod Med (1981) 0.75
Teratomas: concordance in mother and fetus. Am J Obstet Gynecol (1982) 0.75
Cervicovaginal cytology in the diagnosis of recurrent carcinoma of the cervix uteri. Surg Gynecol Obstet (1980) 0.75
Postpartum pain after vaginal delivery. A review of comparative analgesic trials. J Reprod Med (1989) 0.75
Two-dimensional and M-mode echocardiographic evaluation of fetal arrhythmia. Clin Cardiol (1985) 0.75
Immunoglobulin therapy for autoimmune thrombocytopenia purpura during pregnancy. A report of two cases. J Reprod Med (1987) 0.75
Excessive fetal activity: another worrisome sign? South Med J (1983) 0.75
Pregnancy and urinary diversion. Pac Med Surg (1988) 0.75
Conditions affecting nonstress test results. Obstet Gynecol (1982) 0.75
Surveillance techniques other than ultrasonography for detecting fetal malformations. J Reprod Med (1982) 0.75
Probability distributions for measures of placental shape and morphology. Physiol Meas (2014) 0.75
Activity patterns in malformed fetuses. Am J Obstet Gynecol (1982) 0.75
Iron overdose during pregnancy: successful therapy with deferoxamine. Am J Obstet Gynecol (1983) 0.75
Intrapartum fetal heart rate patterns and neonatal intraventricular hemorrhage. Am J Perinatol (1987) 0.75
Clinical experience with ethynodiol diacetate combined with mestronal (metrulen). Nebr State Med J (1968) 0.75
The malformed fetus: diagnosis and pregnancy management. Obstet Gynecol Annu (1985) 0.75
Phencyclidine: biotransformation by the human placenta. Am J Obstet Gynecol (1984) 0.75
Predictability of the distressed term infant. Am J Obstet Gynecol (1981) 0.75
Portal hypertension and hypersplenism in pregnancy secondary to chronic schistosomiasis. A case report. J Reprod Med (1984) 0.75
Fetal activity patterns in hypertensive pregnancies. Clin Exp Hypertens B (1982) 0.75